Rockwell Medical Ownership
| RMTI Stock | USD 1.63 0.04 2.40% |
Shares in Circulation | First Issued 1997-09-30 | Previous Quarter 32 M | Current Value 32.4 M | Avarage Shares Outstanding 5.2 M | Quarterly Volatility 10.8 M |
Rockwell |
Rockwell Stock Ownership Analysis
About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.85. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Rockwell Medical recorded a loss per share of 0.04. The entity had not issued any dividends in recent years. The firm had 1:11 split on the 13th of May 2022. Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan. Rockwell Medical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 300 people. To find out more about Rockwell Medical contact Mark Strobeck at 248 960 9009 or learn more at https://www.rockwellmed.com.Besides selling stocks to institutional investors, Rockwell Medical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Rockwell Medical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Rockwell Medical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Rockwell Medical Quarterly Liabilities And Stockholders Equity |
|
About 13.0% of Rockwell Medical are currently held by insiders. Unlike Rockwell Medical's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Rockwell Medical's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Rockwell Medical's insider trades
Rockwell Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Rockwell Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Rockwell Medical backward and forwards among themselves. Rockwell Medical's institutional investor refers to the entity that pools money to purchase Rockwell Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 97.9 K | Jpmorgan Chase & Co | 2024-09-30 | 94.1 K | Goldman Sachs Group Inc | 2024-12-31 | 82.7 K | Corsair Capital Management Llc | 2024-12-31 | 75 K | Millennium Management Llc | 2024-12-31 | 74.3 K | Perkins Capital Management Inc | 2024-12-31 | 74 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 71.6 K | Northern Trust Corp | 2024-12-31 | 63.4 K | Hightower Advisors, Llc | 2024-12-31 | 57.4 K | Armistice Capital, Llc | 2024-12-31 | 3 M | Vanguard Group Inc | 2024-12-31 | 1.2 M |
Rockwell Medical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Rockwell Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Rockwell Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Rockwell Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mark Strobeck over a month ago Disposition of 2163 shares by Mark Strobeck of Rockwell Medical at 2.055 subject to Rule 16b-3 | ||
Mark Strobeck over a month ago Disposition of 2163 shares by Mark Strobeck of Rockwell Medical at 2.055 subject to Rule 16b-3 | ||
Mark Strobeck over three months ago Disposition of 2163 shares by Mark Strobeck of Rockwell Medical at 3.6852 subject to Rule 16b-3 | ||
Megan Timmins over six months ago Disposition of 3137 shares by Megan Timmins of Rockwell Medical at 1.4 subject to Rule 16b-3 | ||
Skibsted Russell over a year ago Acquisition by Skibsted Russell of 80000 shares of Rockwell Medical subject to Rule 16b-3 | ||
Yocum Richard C over a year ago Acquisition by Yocum Richard C of 100000 shares of Rockwell Medical subject to Rule 16b-3 | ||
Smiley Andrea Heslin over a year ago Acquisition by Smiley Andrea Heslin of 24715 shares of Rockwell Medical subject to Rule 16b-3 |
Rockwell Medical Outstanding Bonds
Rockwell Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Rockwell Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Rockwell bonds can be classified according to their maturity, which is the date when Rockwell Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| ROCKWELL LINS INC Corp BondUS774341AK79 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View |
Currently Active Assets on Macroaxis
When determining whether Rockwell Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rockwell Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rockwell Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rockwell Medical Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rockwell Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rockwell Medical. If investors know Rockwell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.04) | Revenue Per Share | Quarterly Revenue Growth 0.191 | Return On Assets | Return On Equity |
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rockwell Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rockwell Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rockwell Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.